SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-21-000056
Filing Date
2021-05-12
Accepted
2021-05-12 16:35:40
Documents
79
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20210331.htm   iXBRL 10-Q 1573906
2 EX-10.1 exicureexhibit101-33121.htm EX-10.1 60129
3 EX-31.1 exicureexhibit311-33121.htm EX-31.1 8157
4 EX-32.1 exicureexhibit321-33121.htm EX-32.1 6843
10 xcur-20210331_g1.jpg GRAPHIC 403218
11 xcur-20210331_g2.jpg GRAPHIC 154084
  Complete submission text file 0001698530-21-000056.txt   8115879

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20210331.xsd EX-101.SCH 45654
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20210331_cal.xml EX-101.CAL 90733
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20210331_def.xml EX-101.DEF 214649
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20210331_lab.xml EX-101.LAB 604822
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20210331_pre.xml EX-101.PRE 389230
12 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20210331_htm.xml XML 1007037
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 21915648
SIC: 2834 Pharmaceutical Preparations